Authors' self-declared financial conflicts of interest do not impact the Results: Of major cardiovascular trials

Journal of the American College of Cardiology

Volumn 61, Issue 11, 2013, Pages 1137-1143

  Aneja, Ashish ^a   Esquitin, Ricardo ^b   Shah, Kshitij ^c   Iyengar, Rupa ^d   Nisenbaum, Rosane ^e   Melo, Magda ^f   Matthewkutty, Shiny ^d   Sethi, Sanjum S ^d   Mamdani, Muhammad ^f   Farkouh, Michael E ^d,e,f  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF TORONTO   (Canada)

^f ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Cardiovascular; Clinical trial; Conflicts of interest; Financial; Industry; Randomized controlled trials

Indexed keywords

AUTHOR; CARDIOVASCULAR DISEASE; CLINICAL STUDY; CONFLICT OF INTEREST; EMPLOYEE; FINANCIAL MANAGEMENT; FUNDING; MEDICAL LITERATURE; NON PROFIT ORGANIZATION; ORGANIZATION AND MANAGEMENT; PRIORITY JOURNAL; REGISTRATION; REVIEW; SELF REPORT; CLINICAL TRIAL (TOPIC); HUMAN; SELF DISCLOSURE; STANDARD; WRITING;

AUTHORSHIP; CARDIOVASCULAR DISEASES; CLINICAL TRIALS AS TOPIC; CONFLICT OF INTEREST; HUMANS; SELF DISCLOSURE;

MLCS; MLOWN;

EID: 84877137410     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.10.056     Document Type: Article

References (31)

1. Institute of Medicine (US) Committee on Conflict of Interest in Medical Research, Education, and Practice. Lo B, Field MJ, editors. Conflict of Interest in Medical Research, Education, and Practice. Washington, DC: National Academies Press, 2009.
2. Licurse A, Barber E, Joffe S, Gross C. The impact of disclosing financial ties in research and clinical care: a systematic review. Arch Intern Med 2010;170:675- 82.
3. Glaser BE, Bero LA. Attitudes of academic and clinical researchers toward financial ties in research: a systematic review. Sci Eng Ethics 2005;11:553-73.
4. Rochon PA, Gurwitz JH, Simms RW, et al. A study of manufacturersupported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis. Arch Intern Med 1994;154:157- 63.
5. Wahlbeck K, Adams C. Beyond conflict of interest. Sponsored drug trials show more-favourable outcomes. BMJ 1999;318:465.
6. Lexchin J, Bero LA, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 2003;326:1167-70.
7. Bhandari M, Busse JW, Jackowski D, et al. Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials. CMAJ 2004;170:477- 80.
8. Ridker P, Torres J. Reported outcomes in major cardiovascular clinical trials funded by for-profit and not-for-profit organizations: 2000- 2005. JAMA 2006;295:2270-6.
9. Studdert DM, Mello MM, Brennan TA. Financial conflicts of interest in physicians' relationships with the pharmaceutical industry- self-regulation in the shadow of federal prosecution. N Engl J Med 2004;351:1891-900.
10. Rothman DJ, McDonald WJ, Berkowitz CD, et al. Professional medical associations and their relationships with industry: a proposal for controlling conflict of interest. JAMA 2009;301:1367-72.
11. Fontanarosa PB, Flanagin A, DeAngelis CD. Implementation of the ICMJE form for reporting potential conflicts of interest. JAMA 2010;304:1496.
12. Singer, N. Stanford Medical School to Expand Ethics Rules. New York Times [serial online]. March 21, 2010. Available at: http:// www.nytimes.com/2010/03/ 22/health/policy/22docs.html. Accessed May 31, 2012.
13. Pharmaceutical Research and Manufacturers of America (PhRMA). Code on Interactions with Healthcare Professionals. Available at: http://www.phrma.org/ about/principles-guidelines/code-interactionshealthcare- professionals. Accessed May 31, 2012.
14. Roger VL, Go AS, Lloyd-Jones DM, et al. Heart Disease and Stroke Statistics-2012 update. Circulation 2012;125:e2-220.
15. Campbell EG, Gruen RL, Mountford J, Miller LG, Cleary PD, Blumenthal D. A national survey of physician-industry relationships. N Engl J Med 2007;356:1742-50.
16. Office of Extramural Research, National Institutes of Health. Financial Conflict of Interest. Available at: http://grants.nih.gov/grants/ policy/coi. Accessed June 3, 2012.
17. Okike K, Kocher MS, Mehlman CT, Bhandari M. Conflict of interest in orthopaedic research. An association between findings and funding in scientific presentations. J Bone Joint Surg Am 2007;89:608 -13.
18. Office of Extramural Research, National Institutes of Health. Clinical Trials Registration in ClinicalTrials.gov (Public Law 110-85): Competing Applications and Non-Competing Progress Reports. Available at: http://grants.nih.gov/grants/guide/notice-files/not-od-08- 023.html. Accessed June 11, 2012.
19. International Committee of Medical Journal Editors. Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Publishing and Editorial Issues Related to Publication in Biomedical Journals: Obligation to Register Clinical Trials. Available at: http:// www.icmje.org/publishing-10register.html. Accessed May 31, 2012.
20. Mathieu S, Boutron I, Moher D, Altman DG, Ravaud P. Comparison of registered and published primary outcomes in randomized controlled trials. JAMA 2009;302:977- 84.
21. Chan AW, Hróbjartsson A, Haahr MT, Gøtzsche PC, Altman DG. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA 2004; 291:2457- 65.
22. Drazen JM, Van der Weyden MB, Sahni P, et al. Uniform format for disclosure of competing interests in ICMJE journals. JAMA 2010; 303:75- 6.
23. Als-Nielsen B, Chen W, Gluud C, et al. Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events? JAMA 2003;290:921- 8.
24. Conen D, Torres J, Ridker P. Differential citation rates of major cardiovascular clinical trials according to sources of funding: a survey from 2000 to 2005. Circulation 2008;118:1321-7.
25. Rothman DJ, Chimonas S. Academic medical centers' conflict of interest policies. JAMA 2010;304:2294 -5.
26. Hirsch LJ. Conflicts of interest in drug development: the practices of Merck & Co., Inc. Sci Eng Ethics 2002;8:429-42.
27. Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA 2003; 289:454-65.
28. Neuman J, Korenstein D, Ross JS, Keyhani S. Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional study. BMJ 2011;343:d5621.
29. Califf RM, Zarin DA, Kramer JM, Sherman RE, Aberle LH, Tasneem A. Characteristics of clinical trials registered in ClinicalTrials. gov, 2007-2010. JAMA 2012;307:1838-47.
30. Loewenstein G, Sah S, Cain DM. The unintended consequences of conflict of interest disclosure. JAMA 2012;307:669 -70.
31. Austad KE, Kasselheim AS. Conflict of interest disclosure in early education of medical students. JAMA 2011;306:991-2.